Method for the treatment of diabetic macular edema.

Abstract

This disclosure relates to a method for treating diabetic macular edema in a human subject in need, said method comprising (i) an induction phase in which an eye drop formulation containing 1.5% (w / v) dexamethasone is administered topically to the affected eye of said subject, at a dose of 5 to 7 drops daily for 3, 4, 5, 6 weeks, followed by (ii) a maintenance phase in which said eye drop formulation comprising 1.5% (w / v) dexamethasone is administered topically to the affected eye of said subject, at a less frequent daily dose than in the induction phase, for example, 1 to 3 drops.